Tags

Type your tag names separated by a space and hit enter

The prevalence and recognition of chronic kidney disease and anemia in long-term care residents.
Consult Pharm. 2012 Sep; 27(9):627-40.CP

Abstract

OBJECTIVE

To evaluate the prevalence of chronic kidney disease (CKD) and anemia in the long-term care facility, the rate of recognition of these conditions, and the specific interventions used to treat anemia.

DESIGN

Retrospective cross-sectional analysis.

SETTING

Twenty-seven long-term care facilities in Colorado.

PATIENTS, PARTICIPANTS

Had > 90-day residency in the long-term care facility; had index serum creatinine and hemoglobin (Hb) values ± 90 days of the earliest (index) Minimum Data Set (MDS). Data were derived from the AnalytiCare(sm) database (January 1, 2007-September 15, 2008) containing laboratory results, MDS reports, and pharmacy fills. Residents with laboratory-defined CKD had estimated glomerular filtration rates < 60 mL/min/1.73 m(2). Those with laboratory-defined anemia had < 12 g/dL Hb females, < 13 g/dL Hb males. MDS reports indicated recognition of CKD and anemia. Prescription records identified anemia-related pharmacotherapy for anemic residents.

MAIN OUTCOME MEASUREMENTS

Prevalence rates of laboratory-defined CKD and anemia, recognition rates of anemia and CKD, and rates of use of specific anemia pharmacotherapies.

RESULTS

For 838 eligible residents, laboratory findings showed a prevalence rate of 43% for CKD and 46% for anemia. Only 2.8% and 14.6% of residents with laboratory defined CKD had CKD recognized on the index, or any index or postindex MDS, respectively. Anemia recognition rates were 9.6% and 39.9%, respectively. No single anemia prescription therapy class (erythropoiesis stimulating agents, iron, vitamin B(12), or folic acid) was used for more than 10% of all residents with laboratory- or MDS-defined anemia.

CONCLUSION

For CKD and anemia, the lack of concordance between laboratory- and MDS-identified disease should alert health care professionals of potential under-recognition within the long-term care facility.

Authors+Show Affiliations

Informagenics, LLC, Columbus, OH, USA. greardon@informagenics.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

22982747

Citation

Reardon, Gregory, et al. "The Prevalence and Recognition of Chronic Kidney Disease and Anemia in Long-term Care Residents." The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists, vol. 27, no. 9, 2012, pp. 627-40.
Reardon G, Wasserman MR, McKenzie RS, et al. The prevalence and recognition of chronic kidney disease and anemia in long-term care residents. Consult Pharm. 2012;27(9):627-40.
Reardon, G., Wasserman, M. R., McKenzie, R. S., Hord, R. S., Kilpatrick, B., & Bailey, R. A. (2012). The prevalence and recognition of chronic kidney disease and anemia in long-term care residents. The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists, 27(9), 627-40. https://doi.org/10.4140/TCP.n.2012.627
Reardon G, et al. The Prevalence and Recognition of Chronic Kidney Disease and Anemia in Long-term Care Residents. Consult Pharm. 2012;27(9):627-40. PubMed PMID: 22982747.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The prevalence and recognition of chronic kidney disease and anemia in long-term care residents. AU - Reardon,Gregory, AU - Wasserman,Michael R, AU - McKenzie,R Scott, AU - Hord,R Steve, AU - Kilpatrick,Brett, AU - Bailey,Robert A, PY - 2012/9/18/entrez PY - 2012/9/18/pubmed PY - 2012/10/19/medline SP - 627 EP - 40 JF - The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists JO - Consult Pharm VL - 27 IS - 9 N2 - OBJECTIVE: To evaluate the prevalence of chronic kidney disease (CKD) and anemia in the long-term care facility, the rate of recognition of these conditions, and the specific interventions used to treat anemia. DESIGN: Retrospective cross-sectional analysis. SETTING: Twenty-seven long-term care facilities in Colorado. PATIENTS, PARTICIPANTS: Had > 90-day residency in the long-term care facility; had index serum creatinine and hemoglobin (Hb) values ± 90 days of the earliest (index) Minimum Data Set (MDS). Data were derived from the AnalytiCare(sm) database (January 1, 2007-September 15, 2008) containing laboratory results, MDS reports, and pharmacy fills. Residents with laboratory-defined CKD had estimated glomerular filtration rates < 60 mL/min/1.73 m(2). Those with laboratory-defined anemia had < 12 g/dL Hb females, < 13 g/dL Hb males. MDS reports indicated recognition of CKD and anemia. Prescription records identified anemia-related pharmacotherapy for anemic residents. MAIN OUTCOME MEASUREMENTS: Prevalence rates of laboratory-defined CKD and anemia, recognition rates of anemia and CKD, and rates of use of specific anemia pharmacotherapies. RESULTS: For 838 eligible residents, laboratory findings showed a prevalence rate of 43% for CKD and 46% for anemia. Only 2.8% and 14.6% of residents with laboratory defined CKD had CKD recognized on the index, or any index or postindex MDS, respectively. Anemia recognition rates were 9.6% and 39.9%, respectively. No single anemia prescription therapy class (erythropoiesis stimulating agents, iron, vitamin B(12), or folic acid) was used for more than 10% of all residents with laboratory- or MDS-defined anemia. CONCLUSION: For CKD and anemia, the lack of concordance between laboratory- and MDS-identified disease should alert health care professionals of potential under-recognition within the long-term care facility. SN - 0888-5109 UR - https://www.unboundmedicine.com/medline/citation/22982747/The_prevalence_and_recognition_of_chronic_kidney_disease_and_anemia_in_long_term_care_residents_ L2 - https://www.ingentaconnect.com/openurl?genre=article&amp;issn=0888-5109&amp;volume=27&amp;issue=9&amp;spage=627&amp;aulast=Reardon DB - PRIME DP - Unbound Medicine ER -